SCHEMBL2881053

SCHEMBL2881053

OCCC/C=C/CCC(F)(F)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2881054 1.00
SCHEMBL13911335 1.00
Alcohol SCHEMBL3688305 0.94 FAAH (0.33)
SCHEMBL13911337 0.77
SCHEMBL9634063 0.77 FAAH (0.32)
SCHEMBL2881564 0.77
SCHEMBL2883913 0.77
SCHEMBL13905060 0.77
SCHEMBL2881563 0.77
SCHEMBL2883564 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2010536910-A 2010-12-02 JP claimed
EP-2197831-A1 PROCESS FOR PREPARING ESTROGEN-ANTAGONISTIC 11 BETA-FLUORO-17 ALPHA-ALKYLESTRA-1,3,5(10)-TRIENE-3,17-DIOLS HAVING A 7 ALPHA-(XI-ALKYLAMINO-OMEGA-PERFLUOROALKYL)ALKYL SIDE CHAIN AND ALPHA-ALKYL(AMINO)-OMEGA-PERFLUORO(ALKYL)ALKANES AND PROCESSES FOR THEIR PREPARATION Bayer Schering Pharma Aktiengesellschaft (DE) 2010-06-23 EP claimed
EP-2033948-A1 Process for preparing Estrogen-antagonistic 11beta-Fluoro-17alpha-alkylestra-1,3,5 (10)-triene-3, 17-diols having a 7alpha-(xi-Alkylamino-omega-perfluoroalkyl)alkyl side chain and alpha-Alkyl(amino)-omega-perfluoro(alkyl)alkanes and processes for their preparation Bayer Schering Pharma Aktiengesellschaft (DE) 2009-03-11 EP claimed
WO-2009027108-A1 PROCESS FOR PREPARING ESTROGEN-ANTAGONISTIC 11 β-FLUORO-17α-ALKYLESTRA-1,3,5(10)-TRIENE-3,17-DIOLS HAVING A 7α-(ξ-ALKYLAMINO-ω-PERFLUOROALKYL)ALKYL SIDE CHAIN AND α-ALKYL(AMINO)-ω-PERFLUORO(ALKYL)ALKANES AND PROCESSES FOR THEIR PREPARATION BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-03-05 WO claimed
US-20090062558-A1 Process for preparing Estrogen-antagonistic 11 beta-Fluoro-17alpha-alkylestra-1,3,5(10)-triene-3,17-diols having a 7alpha-(xi-Alkylamino-omega-perfluoroalkyl)alkyl side chain and alpha-Alkyl(amino)-omega-perfluoro(alkyl)alkanes and Processes for their Preparation BAYER SCHERING PHARMA AG (DE) 2009-03-05 US claimed
EP-2197831-A1 PROCESS FOR PREPARING ESTROGEN-ANTAGONISTIC 11 BETA-FLUORO-17 ALPHA-ALKYLESTRA-1,3,5(10)-TRIENE-3,17-DIOLS HAVING A 7 ALPHA-(XI-ALKYLAMINO-OMEGA-PERFLUOROALKYL)ALKYL SIDE CHAIN AND ALPHA-ALKYL(AMINO)-OMEGA-PERFLUORO(ALKYL)ALKANES AND PROCESSES FOR THEIR PREPARATION Bayer Schering Pharma Aktiengesellschaft (DE) 2010-06-23 EP disclosed
EP-2033948-A1 Process for preparing Estrogen-antagonistic 11beta-Fluoro-17alpha-alkylestra-1,3,5 (10)-triene-3, 17-diols having a 7alpha-(xi-Alkylamino-omega-perfluoroalkyl)alkyl side chain and alpha-Alkyl(amino)-omega-perfluoro(alkyl)alkanes and processes for their preparation Bayer Schering Pharma Aktiengesellschaft (DE) 2009-03-11 EP disclosed
WO-2009027108-A1 PROCESS FOR PREPARING ESTROGEN-ANTAGONISTIC 11 β-FLUORO-17α-ALKYLESTRA-1,3,5(10)-TRIENE-3,17-DIOLS HAVING A 7α-(ξ-ALKYLAMINO-ω-PERFLUOROALKYL)ALKYL SIDE CHAIN AND α-ALKYL(AMINO)-ω-PERFLUORO(ALKYL)ALKANES AND PROCESSES FOR THEIR PREPARATION BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-03-05 WO disclosed
US-20090062558-A1 Process for preparing Estrogen-antagonistic 11 beta-Fluoro-17alpha-alkylestra-1,3,5(10)-triene-3,17-diols having a 7alpha-(xi-Alkylamino-omega-perfluoroalkyl)alkyl side chain and alpha-Alkyl(amino)-omega-perfluoro(alkyl)alkanes and Processes for their Preparation BAYER SCHERING PHARMA AG (DE) 2009-03-05 US disclosed